Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 Jan;47(1):34–40. doi: 10.1136/thx.47.1.34

Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management.

A A Jeffrey 1, P M Warren 1, D C Flenley 1
PMCID: PMC463551  PMID: 1539142

Abstract

BACKGROUND: On the basis of a retrospective survey by this unit it was suggested that patients with acute ventilatory failure should be given sufficient controlled oxygen treatment to raise the arterial oxygen tension (PaO2) to above 6.6 kPa, with the addition of a respiratory stimulant if the hydrogen ion concentration ([H+]) rose above 55 nmol/l and assisted ventilation if the patient remained acidotic despite these measures. This study was designed to verify the prognostic factors that determine survival in acute ventilatory failure and determine the outcome when our guidelines were implemented. METHODS: One hundred and thirty nine episodes of acute hypercapnic (type II) respiratory failure were studied prospectively in 95 patients admitted with acute exacerbations of chronic obstructive lung disease. Patients had to have a PaO2 below 6.6 kPa and an arterial carbon dioxide tension (PaCO2) above 6.6 kPa while breathing air. RESULTS: The mortality associated with episodes of acute ventilatory failure was 12%. Patients who died tended to be older and were significantly more acidotic, hypotensive, and uraemic on admission than those who survived, but they had similar degrees of hypoxaemia and hypercapnia. Death occurred in 10 of the 39 episodes in which arterial [H+] rose to 55 nmol/l or above, compared with seven of the 100 episodes in which it remained below 55 nmol/l. The respiratory stimulant doxapram was used in 37 episodes and was associated with a reduction in [H+] below 55 nmol/l within 24 hours in 23 episodes. Assisted ventilation was used in only four episodes. CONCLUSION: Arterial [H+] is an important prognostic factor for survival. Most patients treated according to the guidelines outlined above can be managed successfully without assisted ventilation.

Full text

PDF
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asmundsson T., Kilburn K. H. Survival of acute respiratory failure. A study of 239 episodes. Ann Intern Med. 1969 Mar;70(3):471–485. doi: 10.7326/0003-4819-70-3-471. [DOI] [PubMed] [Google Scholar]
  2. Bone R. C., Pierce A. K., Johnson R. L., Jr Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am J Med. 1978 Dec;65(6):896–902. doi: 10.1016/0002-9343(78)90740-4. [DOI] [PubMed] [Google Scholar]
  3. Burk R. H., George R. B. Acute respiratory failure in chronic obstructive pulmonary disease. Immediate and long-term prognosis. Arch Intern Med. 1973 Dec;132(6):865–868. [PubMed] [Google Scholar]
  4. Flenley D. C. Interpretation of blood-gas and acid-base data. Br J Hosp Med. 1978 Oct;20(4):384–passim. [PubMed] [Google Scholar]
  5. Kettel L. J., Diener C. F., Morse J. O., Stein H. F., Burrows B. Treatment of acute respiratory acidosis in chronic obstructive lung disease. JAMA. 1971 Sep 13;217(11):1503–1508. [PubMed] [Google Scholar]
  6. Martin T. R., Lewis S. W., Albert R. K. The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest. 1982 Sep;82(3):310–314. doi: 10.1378/chest.82.3.310. [DOI] [PubMed] [Google Scholar]
  7. Moser K. M., Luchsinger P. C., Adamson J. S., McMahon S. M., Schlueter D. P., Spivack M., Weg J. G. Respiratory stimulation with intravenous doxapram in respiratory failure. A double-blind co-operative study. N Engl J Med. 1973 Mar 1;288(9):427–431. doi: 10.1056/NEJM197303012880901. [DOI] [PubMed] [Google Scholar]
  8. Seriff N. S., Khan F., Lazo B. J. Acute respiratory failure. Current concepts of pathophysiology and management. Med Clin North Am. 1973 Nov;57(6):1539–1550. doi: 10.1016/s0025-7125(16)32208-8. [DOI] [PubMed] [Google Scholar]
  9. Sluiter H. J., Blokzijl E. J., van Dijl W., van Haeringen J. R., Hilvering C., Steenhuis E. J. Conservative and respirator treatment of acute respiratory insufficiency in patients with chronic obstructive lung disease. A reappraisal. Am Rev Respir Dis. 1972 Jun;105(6):932–943. doi: 10.1164/arrd.1972.105.6.932. [DOI] [PubMed] [Google Scholar]
  10. Vandenbergh E., Van de Woestijne K. P., Gyselen A. Conservative treatment of acute respiratory failure in patients with chronic obstructive lung disease. Am Rev Respir Dis. 1968 Jul;98(1):60–69. doi: 10.1164/arrd.1968.98.1.60. [DOI] [PubMed] [Google Scholar]
  11. Warren P. M., Flenley D. C., Millar J. S., Avery A. Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-68 and 1970-76. Lancet. 1980 Mar 1;1(8166):467–470. doi: 10.1016/s0140-6736(80)91008-9. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES